Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
General Physician
M.B.B.S, M.Sc. (Physiology), D.Diab.
Diabetologist
M.B.B.S., MSc In Diabetes & Endocrinology, DHHM, Diabetes Certificate Course
Diabetologist
M.B.B.S., MSc In Diabetes & Endocrinology, DHHM, Diabetes Certificate Course
Gastroenterologist
MBBS, FRCP, FEBGH, MRCP, CCST
Internal Medicine Specialist
MBBS, MD (USA), MCPS (Med), FCPS (Internal Medicine), PhD (Internal Medicine and G.E) , ACLS AHA (American Heart Association)
Internal Medicine Specialist
MBBS, MD (USA), MCPS (Med), FCPS (Internal Medicine), PhD (Internal Medicine and G.E) , ACLS AHA (American Heart Association)
Consultant Physician
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Adult Infectious Diseases)
Consultant Physician
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Adult Infectious Diseases)
Internal Medicine Specialist
MBBS, MCPS
Diabetologist
MBBS, MRCGP , MCPS (Family Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures